The

Cancer genetics

Journal

NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891

Informations de publication

Date de publication:
2019
Historique:
received: 29 03 2019
accepted: 30 08 2019
entrez: 9 11 2019
pubmed: 9 11 2019
medline: 9 11 2019
Statut: epublish

Résumé

Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes

Identifiants

pubmed: 31700994
doi: 10.1038/s41523-019-0127-5
pii: 127
pmc: PMC6825205
doi:

Types de publication

Journal Article

Langues

eng

Pagination

38

Subventions

Organisme : Cancer Research UK
ID : 10124
Pays : United Kingdom
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA116167
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA116201
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM130423
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA233191
Pays : United States
Organisme : Cancer Research UK
ID : 10118
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA192393
Pays : United States
Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom

Investigateurs

Rosemary Balleine (R)
Robert Baxter (R)
Stephen Braye (S)
Jane Carpenter (J)
Jane Dahlstrom (J)
John Forbes (J)
C Soon Lee (CS)
Deborah Marsh (D)
Adrienne Morey (A)
Nirmala Pathmanathan (N)
Rodney Scott (R)
Peter Simpson (P)
Allan Spigelman (A)
Nicholas Wilcken (N)
Desmond Yip (D)
Nikolajs Zeps (N)
Muriel Belotti (M)
Ophélie Bertrand (O)
Anne-Marie Birot (AM)
Bruno Buecher (B)
Sandrine Caputo (S)
Anaïs Dupré (A)
Emmanuelle Fourme (E)
Marion Gauthier-Villars (M)
Lisa Golmard (L)
Marine Le Mentec (M)
Virginie Moncoutier (V)
Antoine de Pauw (A)
Claire Saule (C)
Nadia Boutry-Kryza (N)
Alain Calender (A)
Sophie Giraud (S)
Mélanie Léone (M)
Brigitte Bressac-de-Paillerets (B)
Olivier Caron (O)
Marine Guillaud-Bataille (M)
Yves-Jean Bignon (YJ)
Nancy Uhrhammer (N)
Valérie Bonadona (V)
Christine Lasset (C)
Pascaline Berthet (P)
Laurent Castera (L)
Dominique Vaur (D)
Violaine Bourdon (V)
Catherine Noguès (C)
Tetsuro Noguchi (T)
Cornel Popovici (C)
Audrey Remenieras (A)
Hagay Sobol (H)
Isabelle Coupier (I)
Pascal Pujol (P)
Claude Adenis (C)
Aurélie Dumont (A)
Françoise Révillion (F)
Danièle Muller (D)
Emmanuelle Barouk-Simonet (E)
Françoise Bonnet (F)
Virginie Bubien (V)
Michel Longy (M)
Nicolas Sevenet (N)
Laurence Gladieff (L)
Rosine Guimbaud (R)
Viviane Feillel (V)
Christine Toulas (C)
Hélène Dreyfus (H)
Christine Dominique Leroux (CD)
Magalie Peysselon (M)
Christine Rebischung (C)
Clémentine Legrand (C)
Amandine Baurand (A)
Geoffrey Bertolone (G)
Fanny Coron (F)
Laurence Faivre (L)
Caroline Jacquot (C)
Sarab Lizard (S)
Caroline Kientz (C)
Marine Lebrun (M)
Fabienne Prieur (F)
Sandra Fert-Ferrer (S)
Véronique Mari (V)
Laurence Vénat-Bouvet (L)
Stéphane Bézieau (S)
Capucine Delnatte (C)
Isabelle Mortemousque (I)
Chrystelle Colas (C)
Florence Coulet (F)
Florent Soubrier (F)
Mathilde Warcoin (M)
Myriam Bronner (M)
Johanna Sokolowska (J)
Marie-Agnès Collonge-Rame (MA)
Alexandre Damette (A)
Paul Gesta (P)
Hakima Lallaoui (H)
Jean Chiesa (J)
Denise Molina-Gomes (D)
Olivier Ingster (O)
Sylvie Manouvrier-Hanu (S)
Sophie Lejeune (S)
Morteza Aghmesheh (M)
Sian Greening (S)
David Amor (D)
Mike Gattas (M)
Leon Botes (L)
Michael Buckley (M)
Michael Friedlander (M)
Jessica Koehler (J)
Bettina Meiser (B)
Mona Saleh (M)
Elizabeth Salisbury (E)
Alison Trainer (A)
Kathy Tucker (K)
Yoland Antill (Y)
Alexander Dobrovic (A)
Andrew Fellows (A)
Stephen Fox (S)
Marion Harris (M)
Sophie Nightingale (S)
Kelly Phillips (K)
Joe Sambrook (J)
Heather Thorne (H)
Shane Armitage (S)
Leanne Arnold (L)
Rosemary Balleine (R)
Rick Kefford (R)
Judy Kirk (J)
Edwina Rickard (E)
Patti Bastick (P)
Jonathan Beesley (J)
Nick Hayward (N)
Amanda Spurdle (A)
Logan Walker (L)
John Beilby (J)
Christobel Saunders (C)
Ian Bennett (I)
Anneke Blackburn (A)
Michael Bogwitz (M)
Clara Gaff (C)
Geoff Lindeman (G)
Nick Pachter (N)
Clare Scott (C)
Adrienne Sexton (A)
Jane Visvader (J)
Jessica Taylor (J)
Ingrid Winship (I)
Meagan Brennan (M)
Melissa Brown (M)
Juliet French (J)
Stacey Edwards (S)
Matthew Burgess (M)
Jo Burke (J)
Briony Patterson (B)
Phyllis Butow (P)
Bronwyn Culling (B)
Liz Caldon (L)
David Callen (D)
Deepa Chauhan (D)
Maurice Eisenbruch (M)
Louise Heiniger (L)
Manisha Chauhan (M)
Alice Christian (A)
Joanne Dixon (J)
Alexa Kidd (A)
Paul Cohen (P)
Alison Colley (A)
Georgina Fenton (G)
Ashley Crook (A)
Rebecca Dickson (R)
Michael Field (M)
Deborah Marsh (D)
James Cui (J)
Margaret Cummings (M)
Sarah-Jane Dawson (SJ)
Anna DeFazio (A)
Martin Delatycki (M)
Tracy Dudding (T)
Ted Edkins (T)
Gelareh Farshid (G)
James Flanagan (J)
Peter Fong (P)
Laura Forrest (L)
David Gallego-Ortega (D)
Peter George (P)
Grantley Gill (G)
James Kollias (J)
Eric Haan (E)
Stewart Hart (S)
Mark Jenkins (M)
Clare Hunt (C)
Sunil Lakhani (S)
Lara Lipton (L)
Liz Lobb (L)
Graham Mann (G)
Sue Anne McLachlan (SA)
Shona O'Connell (S)
Sarah O'Sullivan (S)
Ellen Pieper (E)
Bridget Robinson (B)
Jodi Saunus (J)
Elizabeth Scott (E)
Rodney Scott (R)
Andrew Shelling (A)
Peter Simpson (P)
Rachael Williams (R)
Mary Ann Young (MA)

Informations de copyright

© The Author(s) 2019.

Déclaration de conflit d'intérêts

Competing interestsC.I. reports consulting with AstraZeneca and Pfizer and her institution receives research support for Tesaro, AstraZeneca, and Pfizer. B.Y.K. served on Invitae Corporation’s Advisory Board from 2017 to 2018. K.P. reports receiving fee, paid to his institution, for lectures and/or participation in advisory board of AstraZeneca and Pfizer and travel support from AstraZeneca and Pfizer. Jordi Surrallés’ institution received research support from Rocket Pharmaceuticals. The remaining authors declare no competing interests.

Références

JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Mol Cell. 2009 Dec 25;36(6):943-53
pubmed: 20064461
N Engl J Med. 2014 Aug 7;371(6):497-506
pubmed: 25099575
Am J Hum Genet. 2007 Dec;81(6):1186-200
pubmed: 17999359
Genet Med. 2018 Apr;20(4):458-463
pubmed: 28837157
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
J Clin Oncol. 2016 Aug 10;34(23):2750-60
pubmed: 27269948
Oncotarget. 2017 Mar 3;8(31):50930-50940
pubmed: 28881617
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
J Natl Cancer Inst. 2018 Aug 1;110(8):855-862
pubmed: 30099541
JAMA Oncol. 2017 Sep 01;3(9):1245-1248
pubmed: 28033443
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Hum Mol Genet. 2015 Sep 15;24(18):5345-55
pubmed: 26130695
DNA Repair (Amst). 2015 Feb;26:54-64
pubmed: 25583207
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15172-7
pubmed: 25288723
N Engl J Med. 2015 Jun 4;372(23):2243-57
pubmed: 26014596
Curr Opin Genet Dev. 2015 Aug;33:32-40
pubmed: 26254775
Breast Cancer Res Treat. 2017 Nov;166(1):217-226
pubmed: 28702895
Genet Med. 2018 Apr;20(4):452-457
pubmed: 28837162
EMBO J. 2016 May 2;35(9):909-23
pubmed: 27037238
NPJ Breast Cancer. 2019 Nov 1;5:38
pubmed: 31700994
Nat Protoc. 2006;1(3):1112-6
pubmed: 17406391

Auteurs

Gisella Figlioli (G)

IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy.

Massimo Bogliolo (M)

2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.
3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.
4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain.

Irene Catucci (I)

IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy.

Laura Caleca (L)

Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy.

Sandra Viz Lasheras (SV)

2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.

Roser Pujol (R)

2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.
3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.
4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain.

Johanna I Kiiski (JI)

University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.

Taru A Muranen (TA)

University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.

Daniel R Barnes (DR)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Joe Dennis (J)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Kyriaki Michailidou (K)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
The Cyprus Institute of Neurology & Genetics, Department of Electron Microscopy/Molecular Pathology and The Cyprus School of Molecular Medicine, Nicosia, Cyprus.

Manjeet K Bolla (MK)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Goska Leslie (G)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Cora M Aalfs (CM)

9Amsterdam UMC, lokatie AMC, Department of Clinical Genetics, Amsterdam, The Netherlands.

Muriel A Adank (MA)

The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Family Cancer Clinic, Amsterdam, The Netherlands.

Julian Adlard (J)

Chapel Allerton Hospital, Yorkshire Regional Genetics Service, Leeds, UK.

Simona Agata (S)

Veneto Institute of Oncology IOV - IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy.

Karen Cadoo (K)

Memorial Sloan-Kettering Cancer Center, Department of Medicine, New York, NY USA.

Bjarni A Agnarsson (BA)

Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland.
15University of Iceland, School of Medicine, Reykjavik, Iceland.

Thomas Ahearn (T)

16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

Kristiina Aittomäki (K)

17University of Helsinki, Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland.

Christine B Ambrosone (CB)

18Roswell Park Cancer Institute, Buffalo, NY USA.

Lesley Andrews (L)

Nelune Comprehensive Cancer Care Centre, The Bright Alliance Building, Randwick, NSW Australia.

Hoda Anton-Culver (H)

20University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA USA.

Natalia N Antonenkova (NN)

N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.

Volker Arndt (V)

German Cancer Research Center (DKFZ), Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany.

Norbert Arnold (N)

University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Department of Gynaecology and Obstetrics, and Institute of Clinical Molecular Biology, Kiel, Germany.

Kristan J Aronson (KJ)

Queen's University, Department of Public Health Sciences, and Cancer Research Institute, Kingston, ON Canada.

Banu K Arun (BK)

25University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX USA.

Ella Asseryanis (E)

26Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria.

Bernd Auber (B)

27Hannover Medical School, Institute of Human Genetics, Hannover, Germany.

Päivi Auvinen (P)

28Kuopio University Hospital, Cancer Center, Kuopio, Finland.
29University of Eastern Finland, Institute of Clinical Medicine, Oncology, Kuopio, Finland.
30University of Eastern Finland, Translational Cancer Research Area, Kuopio, Finland.

Jacopo Azzollini (J)

31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy.

Judith Balmaña (J)

32Vall d'Hebron Institute of Oncology, High Risk and Cancer Prevention Group, Barcelona, Spain.
33University Hospital, Vall d'Hebron, Department of Medical Oncology, Barcelona, Spain.

Rosa B Barkardottir (RB)

Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland.
34University of Iceland, BMC (Biomedical Centre), Faculty of Medicine, Reykjavik, Iceland.

Daniel Barrowdale (D)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Julian Barwell (J)

35University Hospitals of Leicester NHS Trust, Leicestershire Clinical Genetics Service, Leicester, UK.

Laura E Beane Freeman (LE)

16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

Charles Joly Beauparlant (CJ)

36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada.

Matthias W Beckmann (MW)

University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.

Sabine Behrens (S)

German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.

Javier Benitez (J)

Spanish National Cancer Research Centre (CNIO), Human Genetics Group, Human Cancer Genetics Programme, Madrid, Spain.
40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
41Spanish National Cancer Research Centre (CNIO), Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Madrid, Spain.

Raanan Berger (R)

Chaim Sheba Medical Center, The Institute of Oncology, Ramat Gan, Israel.

Marina Bermisheva (M)

43Ufa Federal Research Center of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia.

Amie M Blanco (AM)

44University of California San Francisco, Cancer Genetics and Prevention Program, San Francisco, CA USA.

Carl Blomqvist (C)

University of Helsinki, Department of Oncology, Helsinki University Hospital, Helsinki, Finland.
46Örebro University Hospital, Department of Oncology, Örebro, Sweden.

Natalia V Bogdanova (NV)

N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
Hannover Medical School, Department of Radiation Oncology, Hannover, Germany.
Hannover Medical School, Gynaecology Research Unit, Hannover, Germany.

Anders Bojesen (A)

49Aarhus University Hospital, Department of Clinical Genetics, Aarhus, Denmark.

Stig E Bojesen (SE)

Copenhagen University Hospital, Copenhagen General Population Study, Herlev and Gentofte Hospital, Herlev, Denmark.
Copenhagen University Hospital, Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Herlev, Denmark.
52University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark.

Bernardo Bonanni (B)

53IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, Italy.

Ake Borg (A)

54Lund University and Skåne University Hospital, Department of Oncology, Lund, Sweden.

Angela F Brady (AF)

55London North West University Hospitals NHS Trust, Northwick Park Hospital, North West Thames Regional Genetics Service, Kennedy Galton Centre, Harrow, UK.

Hiltrud Brauch (H)

56Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
57University of Tübingen, iFIT-Cluster of Excellence, Tübingen, Germany.
58German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

Hermann Brenner (H)

German Cancer Research Center (DKFZ), Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany.
58German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
59German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Division of Preventive Oncology, Heidelberg, Germany.

Thomas Brüning (T)

60Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.

Barbara Burwinkel (B)

61German Cancer Research Center (DKFZ), Molecular Epidemiology Group, C080 Heidelberg, Germany.
University of Heidelberg, Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, Heidelberg, Germany.

Saundra S Buys (SS)

63Huntsman Cancer Institute, Department of Medicine, Salt Lake City, UT USA.

Trinidad Caldés (T)

64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.

Almuth Caliebe (A)

University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Institute of Human Genetics, Kiel, Germany.

Maria A Caligo (MA)

66University Hospital of Pisa, Section of Molecular Genetics, Dept. of Laboratory Medicine, Pisa, Italy.

Daniele Campa (D)

German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.
67University of Pisa, Department of Biology, Pisa, Italy.

Ian G Campbell (IG)

68Peter MacCallum Cancer Center, Research Division, Melbourne, VIC Australia.
69The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia.

Federico Canzian (F)

70German Cancer Research Center (DKFZ), Genomic Epidemiology Group, Heidelberg, Germany.

Jose E Castelao (JE)

Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Oncology and Genetics Unit, Vigo, Spain.

Jenny Chang-Claude (J)

German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.
72University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany.

Stephen J Chanock (SJ)

16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

Kathleen B M Claes (KBM)

73Ghent University, Centre for Medical Genetics, Gent, Belgium.

Christine L Clarke (CL)

74University of Sydney, Westmead Institute for Medical Research, Sydney, NSW Australia.

Anita Collavoli (A)

University and University Hospital of Pisa, Section of Genetic Oncology, Dept. of Laboratory Medicine, Pisa, Italy.

Thomas A Conner (TA)

76Huntsman Cancer Institute, Salt Lake City, UT USA.

David G Cox (DG)

77Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health, London, UK.
78Cancer Research Center of Lyon, INSERM, U1052 Lyon, France.

Cezary Cybulski (C)

79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.

Kamila Czene (K)

80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.

Mary B Daly (MB)

81Fox Chase Cancer Center, Department of Clinical Genetics, Philadelphia, PA USA.

Miguel de la Hoya (M)

64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.

Peter Devilee (P)

82Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands.
83Leiden University Medical Center, Department of Human Genetics, Leiden, The Netherlands.

Orland Diez (O)

84Vall d'Hebron Institute of Oncology (VHIO), Oncogenetics Group, Barcelona, Spain.
85University Hospital Vall d'Hebron, Area of Clinical and Molecular Genetics, Barcelona, Spain.

Yuan Chun Ding (YC)

86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA.

Gillian S Dite (GS)

87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.

Nina Ditsch (N)

88Ludwig Maximilian University of Munich, Department of Gynecology and Obstetrics, Munich, Germany.

Susan M Domchek (SM)

Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA.

Cecilia M Dorfling (CM)

90University of Pretoria, Department of Genetics, Arcadia, South Africa.

Isabel Dos-Santos-Silva (I)

91London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK.

Katarzyna Durda (K)

79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.

Miriam Dwek (M)

92University of Westminster, Department of Biomedical Sciences, Faculty of Science and Technology, London, UK.

Diana M Eccles (DM)

93University of Southampton, Cancer Sciences Academic Unit, Faculty of Medicine, Southampton, UK.

Arif B Ekici (AB)

Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Institute of Human Genetics, University Hospital Erlangen, Erlangen, Germany.

A Heather Eliassen (AH)

95Harvard Medical School, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA USA.
96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA.

Carolina Ellberg (C)

97Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden.

Mikael Eriksson (M)

80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.

D Gareth Evans (DG)

98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.
99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK.

Peter A Fasching (PA)

University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.
100University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, Los Angeles, CA USA.

Jonine Figueroa (J)

16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.
101The University of Edinburgh Medical School, Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
Cancer Research UK Edinburgh Centre, Edinburgh, UK.

Henrik Flyger (H)

Copenhagen University Hospital, Department of Breast Surgery, Herlev and Gentofte Hospital, Herlev, Denmark.

William D Foulkes (WD)

104McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC Canada.

Tara M Friebel (TM)

105Harvard T.H. Chan School of Public Health, Boston, MA USA.
106Dana-Farber Cancer Institute, Boston, MA USA.

Eitan Friedman (E)

107Chaim Sheba Medical Center, The Susanne Levy Gertner Oncogenetics Unit, Ramat Gan, Israel.
108Tel Aviv University, Sackler Faculty of Medicine, Ramat Aviv, Israel.

Marike Gabrielson (M)

80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.

Pragna Gaddam (P)

109Memorial Sloan-Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY USA.

Manuela Gago-Dominguez (M)

110Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Genomic Medicine Group, Galician Foundation of Genomic Medicine, Santiago de Compostela, Spain.
111University of California San Diego, Moores Cancer Center, La Jolla, CA USA.

Chi Gao (C)

112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA.

Susan M Gapstur (SM)

113American Cancer Society, Epidemiology Research Program, Atlanta, GA USA.

Judy Garber (J)

Dana-Farber Cancer Institute, Cancer Risk and Prevention Clinic, Boston, MA USA.

Montserrat García-Closas (M)

16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

José A García-Sáenz (JA)

64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.

Mia M Gaudet (MM)

113American Cancer Society, Epidemiology Research Program, Atlanta, GA USA.

Simon A Gayther (SA)

116Cedars-Sinai Medical Center, The Center for Bioinformatics and Functional Genomics at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA.

Graham G Giles (GG)

87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.
117Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC Australia.
118Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, VIC Australia.

Gord Glendon (G)

119Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada.

Andrew K Godwin (AK)

120Kansas University Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS USA.

Mark S Goldberg (MS)

121McGill University, Department of Medicine, Montréal, QC Canada.
122McGill University, Division of Clinical Epidemiology, Royal Victoria Hospital, Montréal, QC Canada.

David E Goldgar (DE)

123Huntsman Cancer Institute, University of Utah School of Medicine, Department of Dermatology, Salt Lake City, UT USA.

Pascal Guénel (P)

124INSERM, University Paris-Sud, University Paris-Saclay, Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), Villejuif, France.

Angelica M Gutierrez-Barrera (AM)

125University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology and Clinical Genetics Program, Houston, TX USA.

Lothar Haeberle (L)

126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.

Christopher A Haiman (CA)

127University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA USA.

Niclas Håkansson (N)

128Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.

Per Hall (P)

80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.
129Södersjukhuset, Department of Oncology, Stockholm, Sweden.

Ute Hamann (U)

German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.

Patricia A Harrington (PA)

131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.

Alexander Hein (A)

University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.

Jane Heyworth (J)

132The University of Western Australia, School of Population and Global Health, Perth, WA Australia.

Peter Hillemanns (P)

Hannover Medical School, Gynaecology Research Unit, Hannover, Germany.

Antoinette Hollestelle (A)

133Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands.

John L Hopper (JL)

87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.

H Dean Hosgood (HD)

134Albert Einstein College of Medicine, Department of Epidemiology and Public Health, Bronx, NY USA.

Anthony Howell (A)

135University of Manchester, Division of Cancer Sciences, Manchester, UK.

Chunling Hu (C)

136Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA.

Peter J Hulick (PJ)

137NorthShore University HealthSystem, Center for Medical Genetics, Evanston, IL USA.
138The University of Chicago Pritzker School of Medicine, Chicago, IL USA.

David J Hunter (DJ)

96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA.
112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA.
139University of Oxford, Nuffield Department of Population Health, Oxford, UK.

Evgeny N Imyanitov (EN)

140N.N. Petrov Institute of Oncology, St. Petersburg, Russia.

Claudine Isaacs (C)

141Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC USA.

Milena Jakimovska (M)

142Macedonian Academy of Sciences and Arts, Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Skopje, Republic of Macedonia.

Anna Jakubowska (A)

79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.
143Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, Poland.

Paul James (P)

69The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia.
144Peter MacCallum Cancer Center, Parkville Familial Cancer Centre, Melbourne, VIC Australia.

Ramunas Janavicius (R)

145Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Dept. of Molecular and Regenerative Medicine, Vilnius, Lithuania.
State Research Institute Innovative Medicine Center, Vilnius, Lithuania.

Wolfgang Janni (W)

147University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, Germany.

Esther M John (EM)

148Stanford University School of Medicine, Department of Medicine (Oncology) and Stanford Cancer Institute, Stanford, CA USA.

Michael E Jones (ME)

115The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK.

Audrey Jung (A)

German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.

Rudolf Kaaks (R)

German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.

Beth Y Karlan (BY)

149Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA.

Elza Khusnutdinova (E)

43Ufa Federal Research Center of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia.
150Bashkir State Medical University, Department of Medical Genetics, Ufa, Russia.

Cari M Kitahara (CM)

151National Cancer Institute, Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

Irene Konstantopoulou (I)

152National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece.

Stella Koutros (S)

16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

Peter Kraft (P)

96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA.
112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA.

Diether Lambrechts (D)

153VIB, VIB Center for Cancer Biology, Leuven, Belgium.
154University of Leuven, Laboratory for Translational Genetics, Department of Human Genetics, Leuven, Belgium.

Conxi Lazaro (C)

IDIBELL (Bellvitge Biomedical Research Institute),Catalan Institute of Oncology, CIBERONC, Molecular Diagnostic Unit, Hereditary Cancer Program, Barcelona, Spain.

Loic Le Marchand (L)

156University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI USA.

Jenny Lester (J)

149Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA.

Fabienne Lesueur (F)

Inserm U900, Genetic Epidemiology of Cancer team, Paris, France.
158PSL University, Paris, France.
159Institut Curie, Paris, France.
160Mines ParisTech, Fontainebleau, France.

Jenna Lilyquist (J)

161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA.

Jennifer T Loud (JT)

162National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

Karen H Lu (KH)

163University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Clinical Cancer Genetics Program, Houston, TX USA.

Robert N Luben (RN)

164University of Cambridge, Clinical Gerontology, Department of Public Health and Primary Care, Cambridge, UK.

Jan Lubinski (J)

79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.

Arto Mannermaa (A)

30University of Eastern Finland, Translational Cancer Research Area, Kuopio, Finland.
165University of Eastern Finland, Institute of Clinical Medicine, Pathology and Forensic Medicine, Kuopio, Finland.
166Kuopio University Hospital, Imaging Center, Department of Clinical Pathology, Kuopio, Finland.

Mehdi Manoochehri (M)

German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.

Siranoush Manoukian (S)

31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy.

Sara Margolin (S)

129Södersjukhuset, Department of Oncology, Stockholm, Sweden.
Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden.

John W M Martens (JWM)

133Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands.

Tabea Maurer (T)

72University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany.

Dimitrios Mavroudis (D)

168University Hospital of Heraklion, Department of Medical Oncology, Heraklion, Greece.

Noura Mebirouk (N)

Inserm U900, Genetic Epidemiology of Cancer team, Paris, France.
158PSL University, Paris, France.
159Institut Curie, Paris, France.
160Mines ParisTech, Fontainebleau, France.

Alfons Meindl (A)

88Ludwig Maximilian University of Munich, Department of Gynecology and Obstetrics, Munich, Germany.

Usha Menon (U)

University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.

Austin Miller (A)

Roswell Park Cancer Institute, NRG Oncology, Clinical Trials Development Division, Buffalo, NY USA.

Marco Montagna (M)

Veneto Institute of Oncology IOV - IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy.

Katherine L Nathanson (KL)

Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA.

Susan L Neuhausen (SL)

86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA.

William G Newman (WG)

98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.
99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK.

Tu Nguyen-Dumont (T)

171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia.
199The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC Australia.

Finn Cilius Nielsen (FC)

Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark.

Sarah Nielsen (S)

The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL USA.

Liene Nikitina-Zake (L)

174Latvian Biomedical Research and Study Centre, Riga, Latvia.

Kenneth Offit (K)

109Memorial Sloan-Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY USA.
175Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY USA.

Edith Olah (E)

176National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary.

Olufunmilayo I Olopade (OI)

The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL USA.

Andrew F Olshan (AF)

177University of North Carolina at Chapel Hill, Department of Epidemiology, Lineberger Comprehensive Cancer Center, Chapel Hill, NC USA.

Janet E Olson (JE)

161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA.

Håkan Olsson (H)

97Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden.

Ana Osorio (A)

Spanish National Cancer Research Centre (CNIO), Human Genetics Group, Human Cancer Genetics Programme, Madrid, Spain.
40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.

Laura Ottini (L)

178University La Sapienza, Department of Molecular Medicine, Rome, Italy.

Bernard Peissel (B)

31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy.

Ana Peixoto (A)

179Portuguese Oncology Institute, Department of Genetics, Porto, Portugal.

Julian Peto (J)

91London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK.

Dijana Plaseska-Karanfilska (D)

142Macedonian Academy of Sciences and Arts, Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Skopje, Republic of Macedonia.

Timea Pocza (T)

176National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary.

Nadege Presneau (N)

92University of Westminster, Department of Biomedical Sciences, Faculty of Science and Technology, London, UK.

Miquel Angel Pujana (MA)

IDIBELL (Bellvitge Biomedical Research Institute),Catalan Institute of Oncology, CIBERONC, ProCURE, Oncobell, Barcelona, Spain.

Kevin Punie (K)

181Leuven Cancer Institute, University Hospitals Leuven, Multidisciplinary Breast Center, Department of General Medical Oncology, Leuven, Belgium.

Brigitte Rack (B)

147University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, Germany.

Johanna Rantala (J)

182Karolinska Institutet, Clinical Genetics, Stockholm, Sweden.

Muhammad U Rashid (MU)

German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.
183Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Department of Basic Sciences, Lahore, Pakistan.

Rohini Rau-Murthy (R)

175Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY USA.

Gad Rennert (G)

184Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel.

Flavio Lejbkowicz (F)

184Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel.

Valerie Rhenius (V)

131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.

Atocha Romero (A)

185Hospital Universitario Puerta de Hierro, Medical Oncology Department, Madrid, Spain.

Matti A Rookus (MA)

186The Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, The Netherlands.

Eric A Ross (EA)

187Fox Chase Cancer Center, Biostatistics and Bioinformatics Facility, Philadelphia, PA USA.

Maria Rossing (M)

Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark.

Vilius Rudaitis (V)

188Vilnius University, Medical Faculty, Institute of Clinical Medicine, Vilnius, Lithuania.

Matthias Ruebner (M)

126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.

Emmanouil Saloustros (E)

189University Hospital of Larissa, Department of Oncology, Larissa, Greece.

Kristin Sanden (K)

190University of Wisconsin, Cancer Center at ProHealth Care, Waukesha, WI USA.

Marta Santamariña (M)

40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
191Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, Spain.
192Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain.

Maren T Scheuner (MT)

44University of California San Francisco, Cancer Genetics and Prevention Program, San Francisco, CA USA.

Rita K Schmutzler (RK)

193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.
194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.

Michael Schneider (M)

126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.

Christopher Scott (C)

161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA.

Leigha Senter (L)

195The Ohio State University, Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, Columbus, OH USA.

Mitul Shah (M)

131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.

Priyanka Sharma (P)

196University of Kansas Medical Center, Department of Internal Medicine, Division of Oncology, Westwood, KS USA.

Xiao-Ou Shu (XO)

Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN USA.

Jacques Simard (J)

36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada.

Christian F Singer (CF)

26Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria.

Christof Sohn (C)

University of Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany.

Penny Soucy (P)

36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada.

Melissa C Southey (MC)

171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia.
199The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC Australia.

John J Spinelli (JJ)

BC Cancer, Population Oncology, Vancouver, BC Canada.
201University of British Columbia, School of Population and Public Health, Vancouver, BC Canada.

Linda Steele (L)

86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA.

Dominique Stoppa-Lyonnet (D)

202Institut Curie, Service de Génétique, Paris, France.
INSERM U830, Department of Tumour Biology, Paris, France.
204Université Paris Descartes, Paris, France.

William J Tapper (WJ)

205University of Southampton, Faculty of Medicine, Southampton, UK.

Manuel R Teixeira (MR)

179Portuguese Oncology Institute, Department of Genetics, Porto, Portugal.
206University of Porto, Biomedical Sciences Institute (ICBAS), Porto, Portugal.

Mary Beth Terry (MB)

207Columbia University, Department of Epidemiology, Mailman School of Public Health, New York, NY USA.

Mads Thomassen (M)

208Odense University Hospital, Department of Clinical Genetics, Odence C, Denmark.

Jennifer Thompson (J)

137NorthShore University HealthSystem, Center for Medical Genetics, Evanston, IL USA.

Darcy L Thull (DL)

Magee-Womens Hospital, University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, PA USA.

Marc Tischkowitz (M)

104McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC Canada.
210University of Cambridge, Department of Medical Genetics, Cambridge, UK.

Rob A E M Tollenaar (RAEM)

211Leiden University Medical Center, Department of Surgery, Leiden, The Netherlands.

Diana Torres (D)

German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.
212Pontificia Universidad Javeriana, Institute of Human Genetics, Bogota, Colombia.

Melissa A Troester (MA)

177University of North Carolina at Chapel Hill, Department of Epidemiology, Lineberger Comprehensive Cancer Center, Chapel Hill, NC USA.

Thérèse Truong (T)

124INSERM, University Paris-Sud, University Paris-Saclay, Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), Villejuif, France.

Nadine Tung (N)

213Beth Israel Deaconess Medical Center, Department of Medical Oncology, Boston, MA USA.

Michael Untch (M)

Helios Clinics Berlin-Buch, Department of Gynecology and Obstetrics, Berlin, Germany.

Celine M Vachon (CM)

161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA.

Elizabeth J van Rensburg (EJ)

90University of Pretoria, Department of Genetics, Arcadia, South Africa.

Elke M van Veen (EM)

98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.
99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK.

Ana Vega (A)

40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
191Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, Spain.
192Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain.

Alessandra Viel (A)

215Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Division of Functional onco-genomics and genetics, Aviano, Italy.

Barbara Wappenschmidt (B)

193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.
194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.

Jeffrey N Weitzel (JN)

216City of Hope, Clinical Cancer Genetics, Duarte, CA USA.

Camilla Wendt (C)

129Södersjukhuset, Department of Oncology, Stockholm, Sweden.
Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden.

Greet Wieme (G)

73Ghent University, Centre for Medical Genetics, Gent, Belgium.

Alicja Wolk (A)

128Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
217Uppsala University, Department of Surgical Sciences, Uppsala, Sweden.

Xiaohong R Yang (XR)

16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

Wei Zheng (W)

Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN USA.

Argyrios Ziogas (A)

20University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA USA.

Kristin K Zorn (KK)

Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA USA.

Alison M Dunning (AM)

131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.

Michael Lush (M)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Qin Wang (Q)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Lesley McGuffog (L)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Michael T Parsons (MT)

219QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia.

Paul D P Pharoah (PDP)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.

Florentia Fostira (F)

152National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece.

Amanda E Toland (AE)

220The Ohio State University, Department of Cancer Biology and Genetics, Columbus, OH USA.

Irene L Andrulis (IL)

119Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada.
221University of Toronto, Department of Molecular Genetics, Toronto, ON Canada.

Susan J Ramus (SJ)

222University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, NSW Australia.
223The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, NSW Australia.

Anthony J Swerdlow (AJ)

The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK.
The Institute of Cancer Research, Division of Breast Cancer Research, London, UK.

Mark H Greene (MH)

162National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.

Wendy K Chung (WK)

226Columbia University, Departments of Pediatrics and Medicine, New York, NY USA.

Roger L Milne (RL)

87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.
117Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC Australia.
171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia.

Georgia Chenevix-Trench (G)

219QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia.

Thilo Dörk (T)

Hannover Medical School, Gynaecology Research Unit, Hannover, Germany.

Marjanka K Schmidt (MK)

227The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Molecular Pathology, Amsterdam, The Netherlands.
228The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Division of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands.

Douglas F Easton (DF)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.

Paolo Radice (P)

Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy.

Eric Hahnen (E)

193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.
194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.

Antonis C Antoniou (AC)

7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.

Fergus J Couch (FJ)

136Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA.

Heli Nevanlinna (H)

University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.

Jordi Surrallés (J)

2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.
3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.
4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain.
229Department of Genetics, Sant Pau Hospital, Barcelona, Spain.

Paolo Peterlongo (P)

IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy.

Classifications MeSH